0.33 <i>g</i> mitigates muscle atrophy while 0.67 <i>g</i> preserves muscle function and myofiber type composition in mice during spaceflight
As human space exploration advances, understanding how different gravity levels affect skeletal muscle is critical for long-term health. Among the major organ systems, skeletal muscle is particularly sensitive to gravitational unloading, yet the gravity threshold required to maintain homeostasis remains unclear. Using the Multiple Artificial-gravity Research System aboard the International Space Station, mice were exposed to graded gravity levels, microgravity, 0.33<i>g</i>, 0.67<i>g</i>, and 1<i>g</i>, and their muscles were analyzed postflight. In the gravity-sensitive soleus, the cross-sectional area was preserved at 0.33<i>g</i>, while the slow-to-fast myofiber transition was partially suppressed at 0.33<i>g</i> and fully prevented at 0.67<i>g</i>. Functional measures, including forelimb grip strength and electrical impedance myography, indicated that 0.67<i>g</i> was sufficient to maintain muscle performance. Plasma metabolomics identified 11 metabolites with gravity-dependent changes, suggesting potential biomarkers for monitoring physiological adaptation. Collectively, these results identify 0.67<i>g</i> as a critical threshold for mitigating spaceflight-induced muscle atrophy and myofiber type transitions.
Authors
- Akane Yumoto
- Martha Hotz Vitaterna (ORCID: https://orcid.org/0000-0001-6243-2093)
- Dai Shiba (ORCID: https://orcid.org/0000-0003-3808-5428)
- Jennifer C. Coulombe (ORCID: https://orcid.org/0000-0001-6977-0204)
- Shunya Sadaki
- S. Koshiba (ORCID: https://orcid.org/0000-0003-2001-1949)
- Michito Hamada (ORCID: https://orcid.org/0000-0002-4737-1007)
- Ryosuke Tsuji
- Masafumi Muratani (ORCID: https://orcid.org/0000-0002-0276-8000)
- Marie Mortreux (ORCID: https://orcid.org/0000-0001-8567-8184)
- Jason Ciola
- Risa Okada
- Daisuke Kamimura
- Hiroe Kobayashi
- Dong‐Min Sung
- Tatsuya Matsumoto (ORCID: https://orcid.org/0000-0002-9350-6793)
- Akihito Otsuki (ORCID: https://orcid.org/0000-0003-1516-1010)
- Takafumi Suzuki (ORCID: https://orcid.org/0000-0002-3425-8208)
- Yuka Murakami
- Seward B. Rutkove
- Takashi Kudo (ORCID: https://orcid.org/0000-0001-5477-7235)
- Maki Okada (ORCID: https://orcid.org/0009-0005-3331-8191)
- Masayuki Yamamoto (ORCID: https://orcid.org/0000-0002-9073-9436)
- Yuri Inoue
- Ryo Fujita
- Takuto Hayashi
- Satoru Takahashi
- Charles A. Fuller
- Ryo Kurosawa
- Mary L. Bouxsein
Institutions
- Northwestern University (US)
- Brigham and Women's Hospital (US)
- Centre National de la Recherche Scientifique (FR)
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- University of Tsukuba (JP)
- Inserm (FR)
- University of Rhode Island (US)
- Tohoku University (JP)
- Université Paris Cité (FR)
- Japan Aerospace Exploration Agency (JP)
- Institut Necker Enfants Malades (FR)
- Tokyo Medical University Ibaraki Medical Center (JP)
- Tohoku Medical Megabank Organization (JP)
- University of California, Davis (US)
Publication Details
- Journal
- Science Advances
- Published
- 2026-03-13
- DOI
- https://doi.org/10.1126/sciadv.aed2258
- Primary Topic
- Muscle Physiology and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00